The Framingham risk score and heart disease in nonalcoholic fatty liver disease. - Wikidata - awgldk - TriplyDB

The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

http://www.wikidata.org/entity/Q35946523

about

Comorbidities and Metabolic Derangement of NAFLD Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.Nonalcoholic fatty liver disease - A multisystem disease?Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV Obesity-induced hepatic steatosis is mediated by endoplasmic reticulum stress in the subfornical organ of the brain NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Nonalcoholic fatty liver disease and cardiovascular disease Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan.NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels.Non-alcoholic fatty liver disease - the heart of the matter High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women.Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial.Diabetes is an independent predictor of right ventricular dysfunction post ST-elevation myocardial infarction.NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.Role of γ-glutamyl transferase levels in prediction of high cardiovascular risk among patients with non-alcoholic fatty liver disease Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease.Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop CTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism.Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders.Identification of cardiovascular risk components in urban Chinese with metabolic syndrome and application to coronary heart disease prediction: a longitudinal study.Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease.Hepatic steatosis and steatohepatitis: Are they really two distinct entities?Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.Nonalcoholic fatty liver disease - current status and future directions.Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model.Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.Correlation between severity of ultrasonographic nonalcoholic fatty liver disease and cardiometabolic risk among Filipino wellness patients Biochemical Profile of Nonalcoholic Fatty Liver Disease Patients in Eastern India with Histopathological Correlation.MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD).Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease Increased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver

P2860

Q26777147-22662397-63E2-4C0A-AAF4-6BBBF768E028 Q26827665-9B1C68D3-C99B-4822-8A79-0A7326C8DC56 Q27692035-11C28236-3B7B-4D95-9250-D5869B719C4B Q28079077-4C644763-E315-42C6-B4E0-4DE649A24A0D Q28079826-03AB08CB-4F01-4DCB-8D85-BF5ED6600811 Q33578954-67C148D6-7B64-4F48-A344-B784D7C6D54D Q33844463-5F0F28B8-D8B2-461F-B5EA-2AE54D1097DF Q33886952-E19E9E63-8A68-42DE-9BD7-4C76ED3172D4 Q34115861-A2DEFBC8-485F-48F5-9B23-6821086C08BA Q34252404-167ED1DD-85EE-443A-81BC-84DD9D81C59B Q35188136-6218AF75-1D9D-4051-AEE8-B93E2FD4E7BC Q35582273-A9159A85-785A-48EF-B3AA-0C36A80842DC Q35668765-D5CB6B81-0619-4D99-BF88-3581604B9D4D Q35683422-23302BF4-8A18-4199-98F1-04F73E3CC9CC Q36485944-4D205E58-E8F2-4951-BE74-5BC88EC22411 Q36569181-874B5E0F-CD78-4026-8A58-1EDA4780F90F Q36596114-0D611B51-A33D-4330-A3A0-FAA5D88BB1C1 Q36654473-89FA20DD-5D25-4C06-B706-75C9E8AEC01B Q36769687-8A56FCB6-3E3D-49D9-ACA4-E0BC53DD63D2 Q36892592-A20F15A4-B43F-4ECB-A6A5-E2F6A3507F81 Q36987260-DFB03C0C-A0AC-4702-BB78-7DDEF8B87F6C Q37093616-D9A0713A-CB02-4647-837F-6837F6594BDC Q37378928-C15ABCF9-D4BA-4ADD-91EF-769BAA535841 Q37399294-3B856124-9349-423D-BE88-E2EF3717AD39 Q37596189-FF041865-9F78-4BFF-985E-3CB5DDC55FE7 Q37657417-72398A95-4814-48E4-9ADC-3DE0EFC64DB1 Q37705810-D25E835A-75DF-4B7E-BB24-32D0090D4C45 Q38224490-5FB490D8-866D-4DF0-92BB-5A901360F941 Q38261236-7D86FDB9-E5E8-4D89-B144-5658EEF161C4 Q38592767-F0CF71C5-3540-4EAB-B02C-080B39B0D336 Q38642356-081DDA18-82B6-45F3-8277-A73149835888 Q38711424-6499E9E6-FD7D-4212-95B1-D123F408044B Q38974667-B2D3CEA9-0665-4E48-8E34-F2E6957447C4 Q41051779-61742E0B-2CEE-4157-AAE8-534F9A3C7ACE Q51257432-ECD01FAA-D573-410D-89E9-AB3A889ED346 Q55060289-E18006F6-CCD4-489E-8379-15BB48C81F51 Q58589460-DEB91A08-5C0E-4B46-800C-46CA2D1F2E82 Q58799660-EE0BF440-D1BB-416D-BEA3-180E2FFA3590

P2860

The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

http://www.wikidata.org/entity/Q35946523

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

@ast

The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

@en

type

label

The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

@ast

The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

@en

prefLabel

The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

@ast

The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

@en

P1433

Q35946523-E2757F2E-719F-4B30-BC80-FFCBB342FBE4

P1476

Q35946523-5C3EEF43-CB87-4C7D-84CB-BDCEC66E934E

P2093

Q35946523-0F81D6D7-B7A9-427B-8841-4BABD8F98A85

Q35946523-6331BDB2-D445-4568-8D46-1DE703987ABB

Q35946523-9B6A15E6-ED14-4E2F-A9FC-D47615FA1D1F

Q35946523-A9DBEB1D-F6B7-4E98-A3DE-48D26DAE8D2D

Q35946523-F7F88409-CB05-458C-B20A-8147F63E4A6C

P2860

Q35946523-06632E30-F7A7-44C0-980B-E4344E782E9B

Q35946523-1247C527-E054-49C1-AE96-F27D992AF1BA

Q35946523-4DC06C2E-94E3-4D21-BA5E-86C729B51101

Q35946523-611BF761-489E-4A04-9404-1A08238A1ED9

Q35946523-733C6799-E8C8-4CDB-9105-86BA49FAB528

Q35946523-8815398F-C08D-4128-9865-FDAD199E72ED

Q35946523-896D6B4F-1BF5-4CE1-8D8E-9CEAD5844551

Q35946523-8FFA717C-31F0-41DC-A8D6-46762BF62AAE

Q35946523-97BAB989-A52F-4C62-BA1E-C5FE80CE199A

Q35946523-A7ED10CA-00CD-4ABA-9604-85F03C89CE73

P304

Q35946523-D72AC3F7-C507-47C8-8362-818DBCD67442

P31

Q35946523-B51E705A-9CD9-48B1-B777-96EA45973A13

P356

Q35946523-01C02FD6-9483-4F9D-8AD6-494FDD30FB2D

P433

Q35946523-242F31B6-D89D-454E-B6A2-979668B65C56

P478

Q35946523-556F8CAA-FF9A-4CF3-A689-1D3EA143465C

P50

Q35946523-9E7F2A40-0A94-44B8-96F3-3EDFB27A45E5

P577

Q35946523-EB414207-7D99-4D60-A0CC-2061320DF9AC

P698

Q35946523-B22C7816-82DD-4E2E-B874-0EA6F3E76A1F

P932

Q35946523-03DE0775-CC19-4D2F-8B03-5FE9A0ECD991

P356

J.1478-3231.2011.02753.X

P1433

Liver International

P1476

The Framingham risk score and heart disease in nonalcoholic fatty liver disease

@en

P2093

Jennifer St Sauver

http://www.w3.org/2001/XMLSchema#string

Keith D Lindor

http://www.w3.org/2001/XMLSchema#string

Leon A Adams

http://www.w3.org/2001/XMLSchema#string

Paul Angulo

http://www.w3.org/2001/XMLSchema#string

Scott Leverage

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Prediction of first coronary events with the Framingham score: a systematic review.

Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.

History of the Rochester Epidemiology Project.

P304

945-950

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1478-3231.2011.02753.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Sombat Treeprasertsuk

P577

2012-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22299674

http://www.w3.org/2001/XMLSchema#string

P932

3348257

http://www.w3.org/2001/XMLSchema#string